Views on the use of tissue plasminogen activator in acute ischemic stroke: A state-wide survey among neurologists and emergency medicine physicians in Indiana

Journal of Stroke and Cerebrovascular Diseases

Volumn 8, Issue 4, 1999, Pages 207-210

  Meschia, James F ^a,b   Williams, Linda S ^a,b   Fleck, James D ^a,b   Bruno, Askiel ^a,b   Biller, José ^a,b  

^a MAYO CLINIC   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute; Cerebral infarction; Guidelines; Tissue plasminogen activator

Indexed keywords

EID: 0001415503     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3057(99)80068-8     Document Type: Article

References (12)

1. Adams Jr. H.P., Brott T.G., Furlan A.J., et al. Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke 27 (1996) 1711-1718
2. Quality S.S.o.t.A.A.o.N. Practice advisory: Thrombolytic therapy for acute ischemic stroke-summary statement. Neurology 47 (1996) 835-839
3. Clinical Debate. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke?. N Engl J Med 337 (1997) 1309-1313
4. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
5. Donnan G.A., and Davis S.M. Thrombolytic therapy in acute ischaemic stroke: Do the benefits outweigh the risks?. CNS Drugs 6 (1996) 257-262
6. Riggs J.E. Tissue-type plasminogen activator should not be used in acute ischemic stroke. Arch Neurol 53 (1996) 1306-1308
7. Dorman P., and Sandercock P. TPA within 3 hours of acute ischaemic stroke?. Lancet 348 (1996) 1600-1601
8. Williams L.S., Bruno A., Rouch D., et al. Stroke patients' knowledge of stroke. Influence on time to presentation. Stroke 28 (1997) 912-915
9. Jorgensen H.S., Nakayama H., Reith J., et al. Factors delaying hospital admission in acute stroke: The Copenhagen Stroke Study. Neurology 47 (1996) 383-387
10. Hacke W., Kaste M., Fieschi C., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274 (1995) 1017-1025
11. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 28 (1997) 2109-2118
12. Goldstein L.B., Hey L.A., and Laney R. North Carolina Stroke Prevention and Treatment Facilities Survery: rtPA therapy for acute stroke. Stroke 29 (1998) 2069-2072